Clinical trial
Retrospective Chart Review of Patients Undergoing Intravenous Ketamine Treatments for Treatment-resistant Depression
NCT07099235 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Chart Review of Patients Undergoing Intravenous Ketamine Treatments for Treatment-resistant Depression
- Lead sponsor
- Sunnybrook Health Sciences Centre
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2022
- Completion date
- June 29, 2025
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression - major depressive disorder